Kestra Medical Technologies (KMTS) Accounts Payables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Accounts Payables data on file, last reported at $24.0 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $24.0 million, down 6.37% year-over-year; the trailing twelve-month figure through Jan 2026 was $24.0 million (down 6.37% YoY), and the FY2025 annual result was $24.0 million, changed 0.29% from the prior year.
• Accounts Payables grew to $24.0 million in Q1 2026 per KMTS's latest filing, from $20.2 million in the prior quarter.
• Over five years, Accounts Payables peaked at $25.7 million in Q1 2025 and troughed at $18.6 million in Q3 2025.
• A 3-year average of $22.7 million and a median of $23.9 million in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2025 and 2026: Accounts Payables climbed 0.29% in 2025, then retreated 6.37% in 2026.
• A 3-year view of Accounts Payables shows it stood at $23.9 million in 2024, then retreated by 15.42% to $20.2 million in 2025, then rose by 18.87% to $24.0 million in 2026.
• Business Quant data shows KMTS's Accounts Payables at $24.0 million in Q1 2026, $20.2 million in Q4 2025, and $18.6 million in Q3 2025.